Filtered FORsights for Your Topic

The OCC has revised its “Fair Lending” booklet of the Comptroller’s Handbook. Read on to see what this means for your institution.

The FFY 2024 public use file was recently released on the CMS website. Read on for details.

All 340B covered entities that submit claims for separately payable Part B drugs and biologicals face a new requirement starting January 1, 2024.

Businesses that received more than $10,000 in cash in a single transaction or related transactions in 2022 need to do more than file Form 8300 with the IRS by the 15th day after the transaction occurred. They also must provide written statements to…

As the post-COVID-19 work landscape continues to shift, employers and employees should consider state, local, and international tax implications of cross-border business strategies. Read more about what to watch for.

CMS has announced the final OPPS Rules for 2023, confirming that reimbursement payments for 340B drugs will be restored to ASP plus 6%.

The newly passed Consolidated Appropriations Act of 2023 includes multiple provisions anticipated to impact RHCs. Read on for details.

CMS has issued Transmittal 18, which addresses items related to Medicare DSH, bad debts, and uncompensated care. Read on for details.

On December 7, 2022, the Treasury Department announced that the U.S. and Croatia signed the first double income tax treaty between the countries and the first comprehensive tax treaty signed by the U.S. in over a decade. Read on for how this treaty…

Treasury and the IRS recently issued Notice 2023-2, providing interim guidance on the corporate stock repurchase excise tax. Read on for details.